Skip to main content

Prosight Management, LP

13F filer · CIK 0001617201
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$580MU.S. long equity reported on 13F
Positions365 new · 15 closed
Net flow last quarter-$43.9MBuys minus sells
Top 10 positions weight70.7%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202636 positions
LKFTLakefront Biotherapeutics NV$61.3M10.56%3.10%+31.8%Q4 2018
JANXJanux Therapeutics, Inc.$58.4M10.07%6.23%+7.2%Q3 2024
NKTRNektar Therapeutics$56.5M9.74%3.97%+10.2%Q4 2025
BSXBoston Scientific Corp$54.2M9.34%0.09%+59.7%Q3 2025
STTKShattuck Labs, Inc.$41.3M7.12%5.91%+19.1%Q3 2021
INSMINSMED Inc$40M6.90%0.17%Not reportedQ1 2023
ALNYAlnylam Pharmaceuticals, Inc.$29.5M5.09%0.07%+29.1%Q4 2021
SNDXSyndax Pharmaceuticals Inc$26.2M4.52%1.35%+55.8%Q2 2024
KURAKura Oncology, Inc.$22.2M3.82%2.27%-39.8%Q2 2018
ALKSAlkermes plc.$20.7M3.56%0.24%-23.2%Q3 2022
IRTCiRhythm Holdings, Inc.$19.7M3.39%0.50%+1555.0%Q2 2021
VEEVVeeva Systems Inc$18.8M3.25%0.07%+22.8%Q4 2025
ZYMEZymeworks Inc.$17.6M3.04%0.94%+25.1%Q3 2023
ABVXAbivax S.A.$14.3M2.47%0.14%+2.3%Q4 2025
CRNXCrinetics Pharmaceuticals, Inc.$14M2.42%0.35%+7.1%Q2 2025
MLYSMineralys Therapeutics, Inc.$12.1M2.09%0.51%NewQ2 2026
ADCTADC Therapeutics SA$8.37M1.44%6.14%-5.7%Q3 2022
ICUIIcu Medical Inc$7.48M1.29%0.20%+85.8%Q1 2026
ISRGIntuitive Surgical Inc$6.76M1.16%0.00%+325.0%Q1 2025
CRBPCorbus Pharmaceuticals Holdings, Inc.$6.1M1.05%3.48%-6.8%Q1 2024
PRCTPROCEPT BioRobotics Corp$6.06M1.04%0.47%-86.2%Q4 2021
WGSGeneDx Holdings Corp.$5.87M1.01%0.29%-83.7%Q4 2025
OPCHOption Care Health, Inc.$5.68M0.98%0.18%Not reportedQ2 2021
OKUROnKure Therapeutics, Inc.$4.46M0.77%2.42%-54.6%Q4 2024
EBSEmergent BioSolutions Inc.$3.85M0.66%0.90%-28.0%Q1 2026
PFEPfizer Inc$3.26M0.56%0.00%Not reportedQ1 2024
KIDSOrthopediatrics Corp$3.01M0.52%0.61%-47.9%Q3 2020
RCKTRocket Pharmaceuticals, Inc.$2.39M0.41%0.64%+2.4%Q4 2021
ANTXAN2 Therapeutics, Inc.$2.3M0.40%1.31%-8.0%Q1 2026
PLRXPliant Therapeutics, Inc.$1.56M0.27%2.21%-17.8%Q1 2025
TECXTectonic Therapeutic, Inc.$1.37M0.24%0.21%-50.3%Q2 2024
MGTXMeiraGTx Holdings plc$1.22M0.21%0.10%-96.6%Q3 2018
EFOREverforth Inc$1.21M0.21%0.17%Not reportedQ4 2018
RNTXRein Therapeutics, Inc.$1.14M0.20%1.28%+167.3%Q2 2024
COYACoya Therapeutics, Inc.$995K0.17%0.72%-59.6%Q1 2026
IMRXImmuneering Corp$184K0.03%0.14%-70.1%Q2 2024
Q1 2026Reported May 15, 202646 positions
NKTRNektar Therapeutics$52.9M8.67%3.61%+32.5%Q4 2025
BSXBoston Scientific Corp$49.9M8.19%0.05%+278.8%Q3 2025
JANXJanux Therapeutics, Inc.$49.3M8.09%5.83%+48.4%Q3 2024
PRCTPROCEPT BioRobotics Corp$48.6M7.98%3.42%+40.9%Q4 2021
LKFTLakefront Biotherapeutics NV$46.5M7.63%2.35%+44.3%Q4 2018
WGSGeneDx Holdings Corp.$33.6M5.51%1.76%+851.8%Q4 2025
STTKShattuck Labs, Inc.$32.2M5.28%6.62%+110.1%Q3 2021
ADCTADC Therapeutics SA$31.1M5.10%6.53%-2.1%Q3 2022
KURAKura Oncology, Inc.$27.3M4.48%3.78%+32.7%Q2 2018
ALNYAlnylam Pharmaceuticals, Inc.$25.1M4.12%0.06%+344.2%Q4 2021
MGTXMeiraGTx Holdings plc$22.8M3.73%3.23%-18.1%Q3 2018
ALKSAlkermes plc.$18.2M2.98%0.31%Not reportedQ3 2022
SNDXSyndax Pharmaceuticals Inc$18M2.95%0.87%+15.8%Q2 2024
VEEVVeeva Systems Inc$15.2M2.49%0.05%-4.1%Q4 2025
ZYMEZymeworks Inc.$13.5M2.21%0.74%+1.6%Q3 2023
CRNXCrinetics Pharmaceuticals, Inc.$12.7M2.08%0.33%+33.1%Q2 2025
ABVXAbivax S.A.$11.7M1.92%0.13%+517.7%Q4 2025
CONConcentra Group Holdings Parent, Inc.$10.8M1.78%0.40%-43.2%Q2 2025
TERNTerns Pharmaceuticals, Inc.$10.7M1.75%0.18%+113.0%Q4 2025
PHRPhreesia, Inc.$9.22M1.51%1.81%+12.6%Q4 2025
OKUROnKure Therapeutics, Inc.$8.92M1.46%15.76%+163.7%Q4 2024
CRBPCorbus Pharmaceuticals Holdings, Inc.$6.55M1.07%3.93%+1.9%Q1 2024
SDGRSchrodinger, Inc.$5.8M0.95%0.81%Not reportedQ2 2024
EBSEmergent BioSolutions Inc.$5.3M0.87%1.23%NewQ1 2026
ROIVRoivant Sciences Ltd.$4.99M0.82%0.03%-71.3%Q1 2024
KIDSOrthopediatrics Corp$4.8M0.79%1.20%+121.2%Q3 2020
IMVTImmunovant, Inc.$4.37M0.72%0.09%-27.8%Q4 2019
ICUIIcu Medical Inc$3.55M0.58%0.11%NewQ1 2026
TECXTectonic Therapeutic, Inc.$2.47M0.40%0.42%-66.0%Q2 2024
RCKTRocket Pharmaceuticals, Inc.$2.45M0.40%0.63%-8.1%Q4 2021
UPBUpstream Bio, Inc.$2.17M0.36%0.44%NewQ1 2026
PLRXPliant Therapeutics, Inc.$2.1M0.34%2.69%+7.2%Q1 2025
OMEROmeros Corp$1.85M0.30%0.24%NewQ1 2026
ISRGIntuitive Surgical Inc$1.84M0.30%0.00%Not reportedQ1 2025
ANTXAN2 Therapeutics, Inc.$1.76M0.29%1.43%NewQ1 2026
ACETAdicet Bio, Inc.$1.7M0.28%2.61%Not reportedQ4 2025
RGNXREGENXBIO Inc.$1.68M0.27%0.39%NewQ1 2026
COYACoya Therapeutics, Inc.$1.66M0.27%1.79%NewQ1 2026
VKTXViking Therapeutics, Inc.$1.46M0.24%0.04%Not reportedQ3 2018
IRTCiRhythm Holdings, Inc.$1.18M0.19%0.03%Not reportedQ2 2021
TBITrueBlue, Inc.$974K0.16%0.82%-43.7%Q3 2025
IMRXImmuneering Corp$650K0.11%0.48%Not reportedQ2 2024
PVLAPalvella Therapeutics, Inc.$623K0.10%0.03%NewQ1 2026
NVCRNovoCure Ltd$549K0.09%0.04%NewQ1 2026
RNTXRein Therapeutics, Inc.$535K0.09%1.47%-7.0%Q2 2024
TMDXTransMedics Group, Inc.$497K0.08%0.01%NewQ1 2026
Q4 2025Reported Feb 13, 202638 positions
PRCTPROCEPT BioRobotics Corp$43.4M8.97%2.45%+1692.4%Q4 2021
LKFTLakefront Biotherapeutics NV$35.1M7.26%1.63%-6.6%Q4 2018
JANXJanux Therapeutics, Inc.$33M6.82%3.96%+176.5%Q3 2024
ADCTADC Therapeutics SA$29.9M6.18%6.74%+13.5%Q3 2022
KURAKura Oncology, Inc.$26.3M5.43%2.88%-8.3%Q2 2018
MGTXMeiraGTx Holdings plc$25.5M5.27%3.96%-21.5%Q3 2018
NKTRNektar Therapeutics$23.4M4.85%2.72%NewQ4 2025
VEEVVeeva Systems Inc$20.1M4.16%0.05%NewQ4 2025
ICLRIcon PLC$20M4.14%0.14%+0.5%Q4 2024
BSXBoston Scientific Corp$20M4.14%0.01%+176.0%Q3 2025
CONConcentra Group Holdings Parent, Inc.$17.5M3.62%0.69%+46.1%Q2 2025
PHRPhreesia, Inc.$16.5M3.42%1.62%NewQ4 2025
FOLDAmicus Therapeutics, Inc.$16.4M3.38%0.37%-32.7%Q4 2024
SEMSelect Medical Holdings Corp$15.4M3.18%0.83%+18.3%Q1 2022
SNDXSyndax Pharmaceuticals Inc$14M2.89%0.76%-33.7%Q2 2024
ZYMEZymeworks Inc.$14M2.89%0.71%-29.2%Q3 2023
ROIVRoivant Sciences Ltd.$13.6M2.81%0.09%-53.0%Q1 2024
CRNXCrinetics Pharmaceuticals, Inc.$12.2M2.53%0.28%-20.0%Q2 2025
AVTRAvantor, Inc.$10.3M2.13%0.13%Not reportedQ3 2022
STTKShattuck Labs, Inc.$8.69M1.80%3.76%-56.3%Q3 2021
LHLabcorp Holdings Inc.$8.66M1.79%0.04%NewQ4 2025
WGSGeneDx Holdings Corp.$7.15M1.48%0.19%NewQ4 2025
ALNYAlnylam Pharmaceuticals, Inc.$6.8M1.41%0.01%Not reportedQ4 2021
IMVTImmunovant, Inc.$6.19M1.28%0.12%-65.2%Q4 2019
CRBPCorbus Pharmaceuticals Holdings, Inc.$5.57M1.15%3.88%+99.2%Q1 2024
TECXTectonic Therapeutic, Inc.$4.9M1.01%1.25%-38.0%Q2 2024
CDNACareDx, Inc.$4.71M0.97%0.49%-50.4%Q4 2024
TERNTerns Pharmaceuticals, Inc.$3.84M0.79%0.08%NewQ4 2025
RCKTRocket Pharmaceuticals, Inc.$2.61M0.54%0.69%-41.3%Q4 2021
KIDSOrthopediatrics Corp$2.43M0.50%0.54%-55.7%Q3 2020
OKUROnKure Therapeutics, Inc.$2.37M0.49%244.33%+204.9%Q4 2024
BBIOBridgeBio Pharma, Inc.$2.29M0.47%0.02%-88.7%Q4 2022
ABVXAbivax S.A.$2.29M0.47%0.02%NewQ4 2025
ACETAdicet Bio, Inc.$2.11M0.44%2.61%NewQ4 2025
TEMTempus AI, Inc.$2.07M0.43%Not reportedNewQ4 2025
TBITrueBlue, Inc.$2.01M0.42%1.48%+456.8%Q3 2025
PLRXPliant Therapeutics, Inc.$1.9M0.39%2.53%+7493.8%Q1 2025
RNTXRein Therapeutics, Inc.$513K0.11%1.61%-22.1%Q2 2024
Q3 2025Reported Nov 14, 202541 positions
LKFTLakefront Biotherapeutics NV$39.8M9.29%1.75%-35.2%Q4 2018
MGTXMeiraGTx Holdings plc$33.7M7.85%5.08%-10.9%Q3 2018
ADCTADC Therapeutics SA$29.9M6.97%6.63%-28.6%Q3 2022
KURAKura Oncology, Inc.$24.4M5.69%3.17%-13.3%Q2 2018
ISRGIntuitive Surgical Inc$21.8M5.08%0.01%Not reportedQ1 2025
JANXJanux Therapeutics, Inc.$21.1M4.93%1.44%+1.3%Q3 2024
ROIVRoivant Sciences Ltd.$20.2M4.71%0.19%-26.2%Q1 2024
ICLRIcon PLC$19.2M4.47%0.14%+11.1%Q4 2024
SNDXSyndax Pharmaceuticals Inc$15.4M3.60%1.15%-7.1%Q2 2024
BBIOBridgeBio Pharma, Inc.$13.7M3.20%0.14%-44.0%Q4 2022
CRNXCrinetics Pharmaceuticals, Inc.$13.7M3.19%0.35%+10.3%Q2 2025
FOLDAmicus Therapeutics, Inc.$13.5M3.14%0.55%-50.9%Q4 2024
DXCMDexcom Inc$13.1M3.06%0.05%+178.9%Q4 2017
STTKShattuck Labs, Inc.$13M3.04%8.63%-17.9%Q3 2021
ZYMEZymeworks Inc.$12.8M2.99%1.00%-42.8%Q3 2023
CONConcentra Group Holdings Parent, Inc.$12.8M2.98%0.48%+95.5%Q2 2025
IMVTImmunovant, Inc.$11.3M2.63%0.40%+45.7%Q4 2019
SEMSelect Medical Holdings Corp$11.2M2.62%0.71%+147.3%Q1 2022
BHVNBiohaven Ltd.$9.01M2.10%0.57%+11.3%Q1 2025
VRTXVertex Pharmaceuticals Inc / Ma$8.03M1.87%0.01%Not reportedQ4 2020
BSXBoston Scientific Corp$7.43M1.73%0.01%NewQ3 2025
CDNACareDx, Inc.$7.33M1.71%0.98%+66.5%Q4 2024
ACHCAcadia Healthcare Company, Inc.$6.19M1.44%0.28%+18.0%Q4 2017
TECXTectonic Therapeutic, Inc.$5.95M1.39%2.03%-14.2%Q2 2024
KIDSOrthopediatrics Corp$5.72M1.33%1.23%+319.2%Q3 2020
CRBPCorbus Pharmaceuticals Holdings, Inc.$4.34M1.01%2.74%-40.8%Q1 2024
RCKTRocket Pharmaceuticals, Inc.$4.13M0.96%1.17%-19.8%Q4 2021
PRCTPROCEPT BioRobotics Corp$2.75M0.64%0.14%Not reportedQ4 2021
ALGNAlign Technology Inc$2.43M0.57%0.03%NewQ3 2025
ARGXArgenx SE$2.43M0.57%0.01%-85.0%Q1 2025
TWSTTwist Bioscience Corp$2.11M0.49%0.12%NewQ3 2025
AKROAkero Therapeutics, Inc.$1.86M0.43%0.05%NewQ3 2025
CTMXCytomX Therapeutics, Inc.$1.8M0.42%0.34%-83.9%Q3 2024
SGHTSight Sciences, Inc.$1.51M0.35%0.84%-49.5%Q3 2024
OKUROnKure Therapeutics, Inc.$737K0.17%80.14%+67.8%Q4 2024
SDGRSchrodinger, Inc.$699K0.16%0.06%Not reportedQ2 2024
RNTXRein Therapeutics, Inc.$650K0.15%2.26%+32.7%Q2 2024
TBITrueBlue, Inc.$487K0.11%0.27%NewQ3 2025
PRTAProthena Corp Public Ltd Co$195K0.05%0.04%-92.5%Q3 2020
PLRXPliant Therapeutics, Inc.$30.3K0.01%0.03%-97.6%Q1 2025
ACTUActuate Therapeutics, Inc.$5.92K0.00%0.00%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.